ANUH PHARMA Q2 FY27 (STANDALONE) ; NET PROFIT UP 47% AT ₹11 CR (YOY), DOWN 2% (QOQ)

REVENUE FLAT AT ₹185 CR (YOY), DOWN 4% (QOQ) EBITDA UP 43% AT ₹17 CR (YOY), UP 4% (QOQ) MARGINS AT 9.10% VS 6.40% (YOY), 8.40% (QOQ)

ANUH PHARMA LIMITED